Goldman Sachs
CFRX

Goldman Sachs’s ContraFect Corporation CFRX Stock Holding History

Goldman Sachs’s Portfolio CFRX Stock Details CFRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-209
Closed -$1.61K – 6512
2022
Q4 		$1.61K Buy
+209
New +$2.42K ﹤0.01% 5887
2022
Q2 		– Sell
-5,088
Closed -$1.49M – 6962
2022
Q1 		$1.49M Buy
5,088
+62
+1% +$15.1K ﹤0.01% 4496
2021
Q4 		$1.06M Sell
5,026
-2,204
-30% -$605K ﹤0.01% 4796
2021
Q3 		$2.34M Sell
7,230
-316
-4% -$98.3K ﹤0.01% 4040
2021
Q2 		$2.66M Sell
7,546
-2,836
-27% -$928K ﹤0.01% 3945
2021
Q1 		$3.99M Buy
10,382
+7,750
+294% +$3.34M ﹤0.01% 3345
2020
Q4 		$1.06M Buy
+2,632
New +$1.14M ﹤0.01% 4161
2020
Q2 		– Sell
-294
Closed -$135K – 5677
2020
Q1 		$135K Buy
+294
New +$201K ﹤0.01% 4865
2019
Q3 		– Sell
-16
Closed -$7K – 5500
2019
Q2 		$7K Sell
16
-8
-33% -$3.13K ﹤0.01% 5089
2019
Q1 		$8K Buy
+24
New +$10.4K ﹤0.01% 5072
2018
Q2 		– Sell
-47
Closed -$61K – 6192
2018
Q1 		$61K Buy
+47
New +$58K ﹤0.01% 5420
2017
Q4 		– Sell
-60
Closed -$53K – 6832
2017
Q3 		$53K Sell
60
-22
-27% -$20.8K ﹤0.01% 6247
2017
Q2 		$95K Sell
82
-47
-36% -$55.1K ﹤0.01% 6138
2017
Q1 		$186K Sell
129
-119
-48% -$187K ﹤0.01% 5772
2016
Q4 		$347K Sell
248
-3
-1% -$5.3K ﹤0.01% 5368
2016
Q3 		$498K Buy
+251
New +$493K ﹤0.01% 5045

Other funds holding CFRX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BAM
Belpointe Asset Management Reno, Nevada $2.74B AUM 20.71% 1-Year Est. Return

Goldman Sachs's CFRX Position: Q1 2023 in Review

Goldman Sachs sold out of ContraFect Corporation (CFRX) in Q1 2023, closing a stake of 209 shares — an estimated $1.61K sold.

Goldman Sachs first reported a position in CFRX in Q3 2016 and held it in 16 quarters. The position peaked at $3.99M in Q1 2021. 19 funds tracked by Wall St. Rank hold CFRX as of Q1 2023.

  • Goldman Sachs reported no remaining ContraFect Corporation position as of Q1 2023 after selling out during the quarter.
  • Goldman Sachs sold 209 ContraFect Corporation shares in Q1 2023, an estimated $1.61K.
  • Goldman Sachs first reported a position in ContraFect Corporation in Q3 2016 and held it in 16 quarters.
  • Goldman Sachs's ContraFect Corporation position peaked at $3.99M in Q1 2021.
  • 19 funds tracked by Wall St. Rank held ContraFect Corporation as of Q1 2023.

Based on Goldman Sachs's 13F filing for Q1 2023, filed 11 May 2023.